Uromedica: Uromedica Announces the Initiation of its FDA Investigational Device Exemption Trial for ACT to Evaluate its Safety and Efficacy for RX of SUI

Uromedica notes the investigational intent of the ACT trial, a post-operatively adjustable, minimally invasive outpatient procedure, is to assess safety and efficacy for women who suffer from moderate or severe SUI.